ONLY 12 YEARS AGO WE SUCCESSFULLY MAPPED THE HUMAN GENOME AS I SPEAK THE BIOTECH COMPANY BIOVIVA IS CONDUCTING THE FIRST HUMAN TRIALS ON TELOMERE EXTENSION THERAPY